{"name":"Omnicell Inc.","slug":"omnicell","ticker":"OMCL","exchange":"NASDAQ","domain":"omnicell.com","description":"Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensing process. The company also provides Central Med Automation Service for medication dispensing; IV Compounding Service, an in-house compounding system; specialty pharmacy services, including turnkey solution to help health systems establish, manage, and optimize an entity-owned specialty pharmacy; EnlivenHealth platform to digitally enable retail and community pharmacies; medication adherence solutions comprising consumables and medication packaging systems; and technology implementation, customer education and training, program management, and related offerings to professi","hq":"Mountain View, CA","founded":0,"employees":"3525","ceo":"Randall Lipps","sector":"Health IT / Pharmacy Automation","stockPrice":43.15,"stockChange":-0.02,"stockChangePercent":-0.05,"marketCap":"$2.0B","metrics":{"revenue":1225057024,"revenueGrowth":14.9,"grossMargin":43.9,"rdSpend":88672000,"netIncome":2052000,"cash":239220992,"dividendYield":0,"peRatio":98.1,"fiscalYear":"FY2018"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-22","type":"earnings","headline":"Omnicell Reports Fourth Quarter and Full Year 2023 Financial Results","summary":"Omnicell reported fourth quarter and full year 2023 financial results, with revenue increasing 12% year-over-year to $342.4 million.","drugName":"","sentiment":"positive"},{"date":"2023-11-14","type":"deal","headline":"Omnicell Announces Strategic Partnership with Change Healthcare","summary":"Omnicell announced a strategic partnership with Change Healthcare to enhance its medication management solutions and expand its reach in the healthcare market.","drugName":"","sentiment":"positive"},{"date":"2023-09-11","type":"regulatory","headline":"Omnicell Receives FDA Clearance for New Automated Dispensing Cabinet","summary":"Omnicell received FDA clearance for its new automated dispensing cabinet, designed to improve patient safety and reduce medication errors.","drugName":"","sentiment":"positive"}],"realNews":[{"date":"2026-02-26","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizwFBVV95cUxNd2xkYmpKMDVBeENqZ0lLdUpDQmpvWVNTZFRoRFhSZVdJc0lqV2xLV3lJNURzd0laLWttSTUxU2NxVV9nUlFCMXhSemt1d2N0V3Vjc3VIUEs0LWVjR0ZsWUpBTWkzb25ILU1vYmNfZVctVnVfM3lWMWRuRnA1QV9QNVZOUlhoUkVPaEIzRnFMTy1NMm00MUxVRjMwQkRKRU9fTl9HS0JneGFaTzViR05DU1R5djlGOC1oVmpUWFN6cm1XamFsOE13QlNjS0RYT3c?oc=5","date":"2026-02-05","type":"earnings","source":"TradingView","summary":"Omnicell Announces Fiscal Year and Fourth Quarter 2025 Financial Results - TradingView","headline":"Omnicell Announces Fiscal Year and Fourth Quarter 2025 Financial Results","sentiment":"neutral"},{"date":"2026-02-05","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwJBVV95cUxQY0hrN0dQYTZTTHEzbDY3ZVVVY1lIRVVmSzAyeFhfTThPeDBCaFFNNHpCSEhKQVhwSFFEWkUxamlia0hQcktONkJFQjJaOFBHQVBlSm1vcWVCX3RlOEVnRE9YSkZsUmtGQW94RE52UEwwVFFGOWtDM1lCQjR0NkNuRHJ0UDVMeXZzUnhyd0FOa3J1emNiX1BTbGVRcjhPdXNvNzg3djMza2lDc0ZiOWpPbXlUWW5lbGUxYzVDMWFIdjlaamR4MlNURFNseUw0SGpHUktKOXNOT1VzLW1aSlpzRjRsTVk2dWdRUzdYdmstQ2duM2p1MFA0V2x0dTl5Nzk0N3cwNWN3WngycC1ZNklXY0JYMTNIWFlYODhr?oc=5","date":"2025-12-10","type":"pipeline","source":"The Globe and Mail","summary":"Analysts Offer Insights on Healthcare Companies: Genmab (GMAB), Omnicell (OMCL) and Syndax Pharmaceuticals (SNDX) - The Globe and Mail","headline":"Analysts Offer Insights on Healthcare Companies: Genmab (GMAB), Omnicell (OMCL) and Syndax Pharmaceuticals (SNDX)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAJBVV95cUxOQlowM1p1YVE4TUpjOWlHellIQ2JRVnIyYUlvTThJOE11d0dHWHhRbWhRN2FEbHYxcWt2Rzc3QldBVXRBWDBhNUNBZDRweHRoZjNCZVN4T1p1YkpiSncwVFlVYWlYS3BoTXRCZ0RzcVU0SERwZ1I0N2t4N242SnREVXl3ZUd4UktMSFpnS2k0U2NsamxnZ2t6c3BDcG5mUDdiN1ZxbHR5RXZDMjdFM2lCQmVJeXlnQ0NaVlZuTW91bHZ6MDRCMUlVQm0ydVVUX0hXX0hCYlJyd2RmdWtBdkh6MUQtSmRkcldNX05QQ0lNMXR2cXBKeFdKSUJrcjllcS04M2FxbGhSanlpMENuUW5Wb1Azb1g?oc=5","date":"2025-12-08","type":"pipeline","source":"Business Wire","summary":"Announcing Omnicell Titan XT, the Next Generation, Automated Dispensing System Designed to Empower Autonomous Medication Management - Business Wire","headline":"Announcing Omnicell Titan XT, the Next Generation, Automated Dispensing System Designed to Empower Autonomous Medication","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwJBVV95cUxQWjc0Tnhubk51QV9vRTVQWHFmaWxVcmc0cTl2WGlCN0txekJ2TEFZOWRabzNQZ2M3d0RQelVDZFE0Ynl6NThuSHctREhsVmhRT2VFOWFpMHhqM1BQSW0wZVBOcmwxSE5ja1NkeURBRVFjS0o5X3REUzdnMXRRQUpKQ0lvUl9hYTZpdExTcFFFdmF1M1lWVzdXejlPczdaTGsyT2JOUThTckY1Z0owQURsMDRqR19ubTliaFdWM1lIVUx6b1JhbVVMMU8xM0VBaXBsX29HVVE0eGV6bnNnX1dPVGdtNnRSRElnN1JsdnJ5OVdsR1VUdTJWVFdVUWVHY1hsRllzLWtsUEp0bUE?oc=5","date":"2025-11-13","type":"pipeline","source":"Business Wire","summary":"Omnicell Achieves URAC Certification, Strengthening Compliance and Scalability for Health System-Owned Specialty Pharmacies - Business Wire","headline":"Omnicell Achieves URAC Certification, Strengthening Compliance and Scalability for Health System-Owned Specialty Pharmac","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxNNUtjTWdhaUVaTVNIOHBvemh4RmFqc2dkcDJWQ2tDV3JaWXk5SEJlMFdfMUxIS1lhOG5IQ2tnaG1ZNUFCUTBUQ0dsYWN3Mmw3NjBRWS1XcXI3bmVyWDFHaXFYZDZkd3FBb1ZhV0FDNzhnZ296a0RSN2xmZXN3LTlhd3lEeUo1NmJNNWp4bkV5RQ?oc=5","date":"2025-08-26","type":"pipeline","source":"Fort Worth Inc.","summary":"Omnicell Names Baird Radford as Chief Financial Officer - Fort Worth Inc.","headline":"Omnicell Names Baird Radford as Chief Financial Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiV0FVX3lxTE1kZk5wY1ppeWp5bVZmeHJ1dEVkbEcyVDZON085S0dFbHBJNENCTVlfWDVFUm8tS0pmYUhjRThOWWJIYmJEUlBPci0xZEthVHQ5ZWJ1cjQtRQ?oc=5","date":"2025-06-23","type":"pipeline","source":"StockStory","summary":"Omnicell (OMCL) Research Report - StockStory","headline":"Omnicell (OMCL) Research Report","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxOSEUwT3dmRnBjOE00ak44Tkw2WHZHRVVTTTQ3OFVtRm4tTzZyWWdFQnp0MVVFWjRybVdUR3ZLbW1CeUVyRUliaTF2Q1RRaFFabG1pOXRVNWtjbl9YY0N2TU0wX2pqZm90LS1sVjdETTAtNTdudFpCd2JBSlp3VmJPd1BsLUktQXI5WDhLSW1GQ3U4OVU?oc=5","date":"2025-05-15","type":"pipeline","source":"BioSpace","summary":"Omnicell Opens New Innovation Lab in Austin, Texas - BioSpace","headline":"Omnicell Opens New Innovation Lab in Austin, Texas","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxNYXZGM0VhOG5EWXE0Tm9hcDdvM2hRUkxqWThzZjZic0tCczJwU1A3ZEU1OWRONXp3YzNQNEJiMExNUU4tVTVWNVNkZ1FQbEF6NWVuMUgwbkVzZHM2RlB4MjJIUDl4ckZYb0JlUGdpY2pCeEV1dU16dmo0RENIelV1WlY2dnZjdkNFbFl0dDFHN0RHMEFwU01HU1JGTGhKYmt0dWtKd2ZFZFJCaFN1N19sTWpGX0tPWmE3YzZfV0cwT05tX3At?oc=5","date":"2025-05-14","type":"pipeline","source":"Business Wire","summary":"Omnicell Announces New Products for Perioperative and Clinic Settings - Business Wire","headline":"Omnicell Announces New Products for Perioperative and Clinic Settings","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxNc01sQjBSYkcweDJidGNmcjA5TTF4V3BTRkd2bkp5WnMxZWEzY1VjTGh4NVd1WDgyNnFETURhMFhJWnRBMXMxeW9vV3FSYkJUYmViYzhhOHZVdi1VbVVnd0JHX3p3MXRqdDRrQUp1dW9qRklkS1ZRX2NDdkczTE9fbDV2aVZCMUZuSjljSGVVclJ2cS1DbEE?oc=5","date":"2025-03-12","type":"pipeline","source":"Fort Worth Inc.","summary":"Fort Worth-Based Omnicell CFO Nchacha Etta to Step Down as Company Initiates National Search - Fort Worth Inc.","headline":"Fort Worth-Based Omnicell CFO Nchacha Etta to Step Down as Company Initiates National Search","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxQR2g1eXp0VjVlN3c3enlGMU5aZlF1SkgxN1lRYWdjTFZMb3RMOFplZjF6bGlSMDA4VjlkaUUtLXBzazhCaFM4dGlXckhpV0IyeUk4aGQ3Y2syT1hzTjBuVUdzVnZzRnV6Nk9IY213WWsyMTRwLXRHMDVvSjBvLVoycko5aWJDaUx4SGNYcXFKS2h4aWFIbFNSd2pOTElhZXpyU0NyLUl3WXN2RGltQ1V3eDE5eTFRZlJ5M1VQaDdZZTZsdw?oc=5","date":"2025-02-06","type":"earnings","source":"TradingView","summary":"Omnicell Announces Fiscal Year and Fourth Quarter 2024 Results - TradingView","headline":"Omnicell Announces Fiscal Year and Fourth Quarter 2024 Results","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxPZWhEdVdQREdqQTNudjJVTjN2OW13b0R0YS1jTXVXWHhQNnBJejc3blRURTVtel9KSzUtVmFuQS1rampVMTdRMWpTczZ4VloxOWxiWTdBVXB6YVpFTkZrZ2RaOGY4R1dWMG05bFQ4Rmg2SU1oZVdfaEdGM1JHM3dYX1NvdUt4OHd0a0pjUUwtTG5hR1h0SXo0?oc=5","date":"2023-10-20","type":"pipeline","source":"Houlihan Lokey","summary":"Pharmaceutical Strategies Group - Houlihan Lokey","headline":"Pharmaceutical Strategies Group","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxQTkdpRk5lZXJkMy1WdTJ3UmFSOTBPcWdhT19YWVdxVDdMcGNuZnlXbDVXMVg1bTJXRWk1MUVlSHRZNEhjZ01GOTBjM0xtX19sMUtCbTljV3doX05UVFBrLVJ3akFxalItSVVCUFBROVlEb0taNklzQjVRRU56RXpwaC1fYXZnQ2pCOWI1RHBub3R6T1QwSDU0WkNaandjLTJVMmM2NGhxNllObDYtemNpWmhqSzlMcDFwWU5UcWhyVWZEaUdMdDVGc19EaE5ob25qMWc?oc=5","date":"2019-04-24","type":"pipeline","source":"BioSpace","summary":"The University of Tennessee Medical Center Selects Omnicell Solutions to Support Medication Management Strategy - BioSpace","headline":"The University of Tennessee Medical Center Selects Omnicell Solutions to Support Medication Management Strategy","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Pharmacy Automation Systems","Mckesson Corporation","Tallgrass Pharmaceuticals"],"therapeuticFocus":["Pharmacy Automation","Health IT"],"financials":{"source":"sec_edgar+yahoo","revenue":787309000,"revenuePeriod":"2018-12-31","revenueHistory":[{"value":787309000,"period":"2018-12-31"},{"value":716165000,"period":"2017-12-31"},{"value":712714000,"period":"2017-12-31"},{"value":692623000,"period":"2016-12-31"},{"value":692623000,"period":"2016-12-31"}],"grossProfit":503442000,"grossProfitHistory":[{"period":"2025-12-31","value":503442000},{"period":"2024-12-31","value":471003000},{"period":"2023-12-31","value":496840000},{"period":"2022-12-31","value":588987000}],"rdSpend":88672000,"rdSpendHistory":[{"period":"2025-12-31","value":88672000},{"period":"2024-12-31","value":90412000},{"period":"2023-12-31","value":97115000},{"period":"2022-12-31","value":104969000}],"sgaSpend":409610000,"operatingIncome":5160000,"operatingIncomeHistory":[{"period":"2025-12-31","value":5160000},{"period":"2024-12-31","value":337000},{"period":"2023-12-31","value":-34868000},{"period":"2022-12-31","value":-2323000}],"netIncome":2052000,"netIncomeHistory":[{"period":"2025-12-31","value":2052000},{"period":"2024-12-31","value":12531000},{"period":"2023-12-31","value":-20371000},{"period":"2022-12-31","value":5648000}],"eps":0.04,"epsHistory":[{"period":"2025-12-31","value":0.04},{"period":"2024-12-31","value":0.27},{"period":"2023-12-31","value":-0.45},{"period":"2022-12-31","value":0.12}],"cash":196520000,"cashHistory":[{"period":"2025-12-31","value":196520000},{"period":"2024-12-31","value":369201000},{"period":"2023-12-31","value":467972000},{"period":"2022-12-31","value":330362000}],"totalAssets":1974720000,"totalLiabilities":742906000,"totalDebt":204345000,"equity":1231814000,"operatingCashflow":127300000,"operatingCashflowHistory":[{"period":"2025-12-31","value":127300000},{"period":"2024-12-31","value":187722000},{"period":"2023-12-31","value":181094000},{"period":"2022-12-31","value":77781000}],"capex":-57933000,"capexHistory":[{"period":"2025-12-31","value":-57933000},{"period":"2024-12-31","value":-52793000},{"period":"2023-12-31","value":-55016000},{"period":"2022-12-31","value":-60740000}],"freeCashflow":69367000,"dividendsPaid":null,"buybacks":-77600000,"employees":3525,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[{"sga":null,"ebit":null,"ebitda":null,"period":"2026-03-31","revenue":null,"epsBasic":0.25,"netIncome":null,"rdExpense":null,"epsDiluted":0.25,"grossProfit":null,"operatingIncome":null},{"sga":107358000,"ebit":415000,"ebitda":22197000,"period":"2025-12-31","revenue":313984000,"epsBasic":-0.05,"netIncome":-2026000,"rdExpense":22552000,"epsDiluted":-0.05,"grossProfit":130325000,"operatingIncome":415000},{"sga":102238000,"ebit":8244000,"ebitda":29609000,"period":"2025-09-30","revenue":310631000,"epsBasic":0.12,"netIncome":5462000,"rdExpense":24021000,"epsDiluted":0.12,"grossProfit":134503000,"operatingIncome":8244000},{"sga":97985000,"ebit":8120000,"ebitda":29766000,"period":"2025-06-30","revenue":290562000,"epsBasic":0.12,"netIncome":5639000,"rdExpense":21573000,"epsDiluted":0.12,"grossProfit":127678000,"operatingIncome":8120000},{"sga":102029000,"ebit":-11619000,"ebitda":10222000,"period":"2025-03-31","revenue":269668000,"epsBasic":-0.15,"netIncome":-7023000,"rdExpense":20526000,"epsDiluted":-0.15,"grossProfit":110936000,"operatingIncome":-11619000},{"sga":103325000,"ebit":12396000,"ebitda":34606000,"period":"2024-12-31","revenue":306879000,"epsBasic":null,"netIncome":15842000,"rdExpense":26040000,"epsDiluted":null,"grossProfit":141761000,"operatingIncome":12396000}]},"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":43.15,"previousClose":43.17,"fiftyTwoWeekHigh":55,"fiftyTwoWeekLow":26.85,"fiftyTwoWeekRange":"26.85 - 55.0","fiftyDayAverage":37.77,"twoHundredDayAverage":37.44,"beta":0.96,"enterpriseValue":1926283520,"forwardPE":19.7,"priceToBook":1.58,"priceToSales":1.6,"enterpriseToRevenue":1.57,"enterpriseToEbitda":26.17,"pegRatio":0,"ebitda":73610000,"ebitdaMargin":6,"freeCashflow":112564376,"operatingCashflow":155876000,"totalDebt":202180000,"debtToEquity":16.1,"currentRatio":1.5,"returnOnAssets":1.2,"returnOnEquity":1.6,"analystRating":"1.4 - Strong Buy","recommendationKey":"strong_buy","numberOfAnalysts":7,"targetMeanPrice":61.29,"targetHighPrice":70,"targetLowPrice":55,"dividendRate":0,"payoutRatio":0,"fiveYearAvgDividendYield":0,"exDividendDate":0,"insiderHeldPercent":2.2,"institutionHeldPercent":104,"sharesOutstanding":45478909,"floatShares":41953839,"sharesShort":2698062,"shortRatio":4.64,"shortPercentOfFloat":5.9,"epsTrailing":0.44,"epsForward":2.19,"revenuePerShare":26.84,"bookValue":27.36,"officers":[{"age":68,"name":"Mr. Randall A. Lipps","title":"Founder, Executive Chairman, President & CEO"},{"age":55,"name":"Mr. H. Baird Radford III","title":"Executive VP & CFO"},{"age":48,"name":"Mr. Nnamdi N. Njoku","title":"Executive VP & COO"},{"age":47,"name":"Mr. Corey J. Manley J.D.","title":"Executive VP, Chief Legal & Administrative Officer and Corporate Secretary"},{"age":55,"name":"Mr. Brian H. Nutt","title":"VP, Chief Accounting Officer & Corporate Controller"},{"age":null,"name":"Dr. Perry A. Genova Ph.D.","title":"Senior VP & CTO"},{"age":null,"name":"Mr. Tomer  Stavitsky","title":"Senior VP & Chief Corporate Development Officer"},{"age":null,"name":"Ms. Stella  Prefach","title":"Senior VP & Chief Marketing Officer"}],"industry":"Health Information Services","irWebsite":"","website":"https://www.omnicell.com","phone":"877 415 9990"}}